BridgeMD
New treatment option for Glaucoma
Official title Community Based Treatment for (ComBaT) Glaucoma
ClinicalTrials.gov ID: NCT06124521
What this study is testing
- What it's testing
- The purpose of this research is to evaluate if intervention and education can change the behavior of someone's willingness to see an eye care provider to prevent blindness and glaucoma. The researchers are investigating if adding additional resources improves participant access to care.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- Black or African American
- Participated in the screening examination portion of the study
You likely can't join if
- Current eye pain (\> 8 out of 10)
- Sudden decrease in vision (within 1 week)
- Double vision that doesn't stop when you blink and stops no matter what eye you cover (not blurred, but seeing 2 objects)
- Pregnant women
- Prisoners
- Cognitive impairment- unable to give an ocular and social history
See the full eligibility criteria
- Black or African American
- Participated in the screening examination portion of the study
- Current eye pain (\> 8 out of 10)
- Sudden decrease in vision (within 1 week)
- Double vision that doesn't stop when you blink and stops no matter what eye you cover (not blurred, but seeing 2 objects)
- Pregnant women
- Prisoners
- Cognitive impairment- unable to give an ocular and social history
- Moving outside of Michigan or driving distance to the church within 6 months
The study team makes the final eligibility decision.
Where it's taking place
- Ann Arbor, Michigan, United States
- Detroit, Michigan, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ann Arbor, Michigan, United States; Detroit, Michigan, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.